View Post

Israeli Company Set To Begin Testing New Radiation Cancer Therapy

In Clinical Trials by Barbara Jacoby

By: Robin Seaton Jefferson sFrom: forbes.com An Israeli medical technology company is set to begin testing its new radiation cancer therapy in leading medical centers in Italy. The Alpha DaRT (Dіffusіng Alpha-emіtters Radіatіon Therapy) device delivers high-precision alpha radiation that is released when radioactive substances decay inside the tumor and kills cancer cells while sparing the surrounding healthy tissue, the …

View Post

SWOG shares trio of studies at San Antonio breast cancer symposium

In Clinical Trials by Barbara Jacoby

From: eurekalert.org SWOG Cancer Research Network members will share the results of three studies at the San Antonio Breast Cancer Symposium, an international gathering of breast cancer physicians and researchers that starts today, with an estimated 7,500 attendees expected from more than 90 countries. SWOG is an international cancer clinical trials network funded by the National Cancer Institute (NCI), part …

View Post

Patients of African descent are being denied the benefits of cancer breakthroughs. We’re changing that

In Clinical Trials by Barbara Jacoby

By: Jennifer Dent From: statnews.com Death rates from cancer are falling and access to potentially lifesaving treatments is increasing — except among Africans and Americans of African descent. This gap must be closed. Overall, the picture for cancer looks better than it did 30 years ago. In the last two decades, death rates for cancer in the U.S. have declined …

View Post

Helen F. Graham Cancer Center & Research Institute celebrates 15 years of transformative cancer care

In Clinical Trials by Barbara Jacoby

Nationally recognized for multidisciplinary cancer treatment and top enrollment in research clinical trials Celebrating 15 years of caring for patients, the Helen F. Graham Cancer Center & Research Institute has grown to become one of the most advanced cancer centers in the country, recognized for its patient-centered care as well as a robust program of research and clinical trials. “Over …

View Post

Immunotherapy Expands Treatment Options for Metastatic Bladder Cancer

In Clinical Trials by Barbara Jacoby

By: Danielle Ternyila From: targetedonc.com Several recent updates from clinical trials are transforming the treatment landscape for urothelial carcinoma across a variety of subtypes. The use of immunotherapy, in particular, provides patients who progress after standard platinum-based chemotherapy with new hope and a plethora of options. In the metastatic setting, there have been 5 immune checkpoint inhibitors approved by the …

View Post

Grants aim to provide better cancer clinical trial access for military veterans

In Clinical Trials by Barbara Jacoby

Source: swog.org Reviewed by: James Ives, MPsych From: news-medical.net For the fourth year, SWOG Cancer Research Network and its charity, The Hope Foundation for Cancer Research, are giving military veterans better access to cancer clinical trials by providing grant support to U.S. Department of Veterans Affairs medical centers. Under the VA Integration Support Program, medical centers receive a one-time $50,000 …

View Post

New Studies Using CELLSEARCH Circulating Tumor Cell Test to be Featured at San Antonio Breast Cancer Symposium

In Clinical Trials by Barbara Jacoby

Research Adds to Growing Evidence of Clinical Utility of CTCs for the management of Metastatic Breast Cancer Patients Menarini Silicon Biosystems announced today that new data utilizing the company’s CELLSEARCH® Circulating Tumor Cell Test will be presented at the upcoming 2018 San Antonio Breast Cancer Symposium (SABCS). A total of 21 studies will be presented: 20 posters and an oral …

View Post

Targeting Innovation in Small Cell Lung Cancer

In Clinical Trials by Barbara Jacoby

By: Heather Stringer From: curetoday.com After consulting multiple doctors about her ongoing cough and congestion, LeeAnn Devore asked one of her physicians if she might have lung cancer. “He said the symptoms weren’t right,” says Devore, 66, of Magnolia, Texas. Three X-rays in five months confirmed that she had pneumonia in her right lung, yet she wasn’t responding to traditional …

View Post

New Clinical Trial for Triple-Negative Breast Cancer at Sylvester Comprehensive Cancer Center

In Clinical Trials by Barbara Jacoby

Vaccine Designed to Prevent Recurrence Panic washed over Jackie Barrett when she first received her breast cancer diagnosis. “My eyes went dark. I couldn’t hear anything. It was like a train was coming at me,” she says. Jackie’s oncologist explained that her type of breast cancer is called triple-negative because it does not have receptors for estrogen, progesterone or the …

View Post

Building Disease Management Teams to Harness Clinical Trial Growth

In Clinical Trials by Barbara Jacoby

By: Mindy Waizer From: oncnursingnews.com The clinical trials program at the Lehigh Valley Cancer Institute (LVCI) grew exponentially in a short period of time. A great problem to have, certainly, but challenging to the organization. To ensure the successful absorption and growth of new trials, two nurses drove an initiative to reorganize LVCI’s framework of their current disease management teams. …